OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
May 18, 2024
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 17, 2024
Ken Keller, president and CEO, Daiichi Sankyo, discusses the foundation of partnership and takes a look at the future of biotech partnerships at the US Pharma and Biotech Summit.
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
May 16, 2024
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
May 14, 2024
The drug discovery company intends for this new site to increase its reach in the region, supporting growing demands from its Asia-Pacific consumers.
May 13, 2024
EMA’s CHMP recommended treatments for hemophilia A, colorectal cancer, hypertension, overactive bladder, and metastatic breast cancer.
Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.
Adam Covitt, President of Federal Equipment Company, discusses how the company enables CDMO successes with its Techceuticals and PharmParts business brands.
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.